NCT04612751

Phase 1b Study of Dato-DXd in Combination With Immunotherapy With or Without Carboplatin in Advanced or Metastatic Non-Small Cell Lung Cancer

RecruitingPHASE1INTERVENTIONAL

Trial Details

Start: 2021-02-02Est. Completion: 2026-05-04

Enrollment target: 155 participants

Locations

Research Site, La Jolla, California, United States
Research Site, Santa Ana, California, United States
Research Site, St Louis, Missouri, United States
Research Site, Hackensack, New Jersey, United States
Research Site, Cleveland, Ohio, United States
Research Site, Philadelphia, Pennsylvania, United States
Research Site, Dallas, Texas, United States
Research Site, Houston, Texas, United States
Research Site, San Antonio, Texas, United States
Research Site, Fairfax, Virginia, United States
Research Site, Hasselt, Belgium
Research Site, Roeselare, Belgium
Research Site, Aviano, Italy
Research Site, Meldola, Italy
Research Site, Orbassano, Italy
Research Site, Roma, Italy
Research Site, Kōtoku, Japan
Research Site, Sunto-gun, Japan
Research Site, Yokohama, Japan
Research Site, Gdansk, Poland

Other microbiome trials you might be interested in

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid TumorsPhase 1Recruiting

Metastatic Solid TumorRecurrent Solid TumorAdvanced Solid TumorUrinary Bladder NeoplasmTriple Negative Breast CancerNon-small Cell Lung CancerEsophageal CancerPancreatic CancerOvarian CancerCervical CancerHead and Neck Squamous Cell CarcinomaProstate CancerRenal Pelvis CancerBladder Cancer

The purpose of this study is to find out whether the study drug, LY4052031, is safe, tolerable and effective in particip…

Duarte, United StatesEst. completion May 2027

View Trial →

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.